Jose Maria Pelayo-Teran
Overview
Explore the profile of Jose Maria Pelayo-Teran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
616
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mortier P, Vilagut G, Garcia-Mieres H, Alayo I, Ferrer M, Amigo F, et al.
Psychiatry Res
. 2024 Feb;
334:115800.
PMID: 38387166
Little is known about healthcare workers' (HCW) use of healthcare services for mental disorders. This study presents data from a 16-month prospective cohort study of Spanish HCW (n = 4,809),...
2.
de la Fuente-Tomas L, Arranz B, Sierra P, Sanchez-Autet M, Garcia-Blanco A, Gutierrez-Rojas L, et al.
Span J Psychiatry Ment Health
. 2023 Nov;
17(4):215-221.
PMID: 37965877
Introduction: Bipolar disorder (BD) has been reconceptualised as a progressive disorder that develops from mild to severe presentations. An empirical staging model - the Empirically Developed Clinical Staging Model for...
3.
Garrido-Sanchez L, Gomez-Revuelta M, Ortiz-Garcia de la Foz V, Pelayo-Teran J, Juncal-Ruiz M, Ruiz-Veguilla M, et al.
Int J Neuropsychopharmacol
. 2022 Jul;
25(11):900-911.
PMID: 35894865
Background: Antipsychotic choice for the acute phase of a first episode of psychosis (FEP) is of the utmost importance since it may influence long-term outcome. However, head-to-head comparisons between second-generation...
4.
Alonso J, Vilagut G, Mortier P, Ferrer M, Alayo I, Aragon-Pena A, et al.
Rev Psiquiatr Salud Ment (Engl Ed)
. 2021 Jun;
14(2):90-105.
PMID: 34127211
Introduction: Healthcare workers are vulnerable to adverse mental health impacts of the COVID-19 pandemic. We assessed prevalence of mental disorders and associated factors during the first wave of the pandemic...
5.
Gomez-Revuelta M, Pelayo-Teran J, Vazquez-Bourgon J, Ortiz-Garcia de la Foz V, Son J, Ayesa-Arriola R, et al.
Eur Neuropsychopharmacol
. 2021 Mar;
47:74-85.
PMID: 33678469
Selecting the first antipsychotic agent for the acute phase of a first episode of psychosis (FEP) is a critical task that may impact on the long-term outcome. Despite that, there...
6.
Pardo-de-Santayana G, Juncal-Ruiz M, Vazquez-Bourgon J, Riesco-Davila L, Ortiz-Garcia de la Foz V, Pelayo-Teran J, et al.
J Psychiatr Res
. 2021 Jan;
134:150-157.
PMID: 33385633
Higher levels of pro-inflammatory cytokines are consistently found in the serum of first episode psychosis (FEP) patients and this immune dysfunction could contribute to neural harm. On the other hand,...
7.
Alonso J, Vilagut G, Mortier P, Ferrer M, Alayo I, Aragon-Pena A, et al.
Rev Psiquiatr Salud Ment (Engl Ed)
. 2020 Dec;
14(2):90-105.
PMID: 33309957
Introduction: Healthcare workers are vulnerable to adverse mental health impacts of the COVID-19 pandemic. We assessed prevalence of mental disorders and associated factors during the first wave of the pandemic...
8.
Murillo-Garcia N, Setien-Suero E, Pardo-de-Santayana G, Murillo-Garcia M, Pelayo-Teran J, Crespo-Facorro B, et al.
Early Interv Psychiatry
. 2020 Nov;
15(5):1266-1275.
PMID: 33244853
Aim: To explore if the entire duration of active psychosis (DAP) is related to neurocognitive performance at baseline and at 3-year follow-up in patients with first episode psychosis (FEP). Methods:...
9.
Pardo-de-Santayana G, Vazquez-Bourgon J, Gomez-Revuelta M, Ayesa-Arriola R, Ortiz-Garcia de la Foz V, Crespo-Facorro B, et al.
Data Brief
. 2020 May;
30:105599.
PMID: 32395579
This article describes data related to the research study entitled "Duration of active psychosis during early phases of the illness and functional outcome: The PAFIP 10-year follow-up study." [1]. We...
10.
Pardo-de-Santayana G, Vazquez-Bourgon J, Gomez-Revuelta M, Ayesa-Arriola R, Ortiz-Garcia de la Foz V, Crespo-Facorro B, et al.
Schizophr Res
. 2020 Apr;
220:240-247.
PMID: 32276867
Introduction: Longer duration of active psychosis (presence of positive psychotic symptoms) has been associated to worsening of functional and symptomatic outcome in patients with a first-episode of psychosis. There could...